Latest 10-K annual reports

iRhythm Holdings, Inc. reported a 26% increase in revenue and a significantly reduced net loss for 2025, while navigating multiple ongoing legal and regulatory challenges.

GCM Grosvenor Inc. reported significant financial growth for the fiscal year ended December 31, 2025, with total operating revenues increasing 8.5% to $557.6 million and net income attributable to GCM Grosvenor Inc. rising 142.7% to $45.4 million, driven by strong performance in private markets and absolute return strategies.

Consolidated Edison, Inc. announced a significant increase in net income for 2025, driven by utility rate plan approvals and substantial planned investments in energy delivery systems through 2030.

I-80 Gold Corp. reported increased revenue and gold output for 2025, while incurring a significant net loss and advancing its multi-asset development plan in Nevada, including a major recapitalization and Lone Tree Plant refurbishment.

Lincoln National Corporation reports a decrease in net income for 2025 to $1.177 billion, down from $3.275 billion in 2024, driven by capital market impacts on annuity features and reinsurance, despite operational improvements in Life Insurance and Group Protection.

Tractor Supply Company announced a 4.3% net sales increase to $15.52 billion in fiscal 2025, driven by new store openings and the Allivet acquisition, alongside a 1.2% rise in comparable store sales.

Strategy Inc, formerly MicroStrategy, reported a significant net loss of $3.85 billion for fiscal year 2025, driven by a $5.40 billion unrealized loss on its substantial bitcoin holdings, despite growth in subscription services revenue.

Guardant Health, a precision oncology company, reported a 33% increase in total revenue to $982.0 million for fiscal year 2025, driven by growth across its oncology, biopharma, and newly commercialized screening segments, despite continued net losses.

Mirion Technologies reports a significant return to net income in 2025, driven by robust revenue growth and strategic acquisitions in nuclear safety and medical segments.

CSG Systems International, Inc. reported a 2.2% revenue increase to $1.22 billion in 2025, but operating income and diluted EPS declined due to merger-related costs and higher stock-based compensation, as it moves towards a $80.70 per share cash merger with NEC Corporation.

LKQ Corporation's 2025 annual report reveals a slight revenue decline, a goodwill impairment in its Specialty segment, and the initiation of a comprehensive strategic review, including a potential company sale.

DT Midstream achieved significant growth in 2025, driven by the Midwest Pipeline Acquisition and strategic expansions, while maintaining an investment-grade credit rating across all three major agencies.

Bunge Global SA reports a decrease in net income for 2025 to $816 million, impacted by higher debt from the Viterra acquisition, despite increased net sales and segment EBIT.

Gentherm Incorporated reported a significant drop in net income and operating profit for fiscal year 2025, even as it announced a major Reverse Morris Trust transaction with Modine Manufacturing Company's Performance Technologies business.

Select Medical Holdings Corporation reported a significant increase in income from continuing operations for 2025, alongside strategic executive promotions and ongoing evaluation of a take-private proposal.

Travere Therapeutics' 2025 annual report highlights significant revenue growth from FILSPARI, progress in its FSGS and HCU programs, and strategic partnerships, despite ongoing clinical and market challenges.

Kaiser Aluminum Corporation reported a significant increase in net income and Adjusted EBITDA for fiscal year 2025, driven by improved product pricing and mix, despite a slight decrease in shipment volume.

Live Nation Entertainment, Inc. achieved record revenue and operating income in 2025, driven by strong global concert demand and venue expansion, despite a significant decline in net income due to tax adjustments and ongoing antitrust litigation.

TechnipFMC plc reported significant financial and operational improvements in 2025, driven by robust Subsea segment performance, substantial debt reduction, and increased shareholder distributions.

Morgan Stanley announced robust financial results for the year ended December 31, 2025, with significant increases in net revenues, net income, and diluted earnings per share, alongside improved efficiency and capital strength.

ICU Medical reported a net income of $0.732 million for fiscal year 2025, a significant improvement from prior losses, driven by strategic divestitures and gross margin expansion, despite a revenue decline and ongoing FDA regulatory challenges.

Energy Transfer LP reports a 3% increase in Adjusted EBITDA to $15.98 billion for fiscal year 2025, driven by midstream and interstate transportation growth and strategic acquisitions, despite a net income decrease.

Broadstone Net Lease, Inc. reports significant investment activity and robust financial performance for 2025, driven by portfolio growth and strategic capital management.

Blue Owl Capital Inc. announced significant growth in Assets Under Management to $307.4 billion in 2025, alongside record fundraising, despite a decline in net income attributable to Class A shareholders.

Peabody Energy reported a net loss of $52.9 million for 2025, a significant decline from the prior year, driven by lower seaborne coal prices and costs from a terminated acquisition, despite increased production volumes.

Equifax Inc. reported robust financial performance for fiscal year 2025, driven by broad revenue growth and increased shareholder returns.

PTC Therapeutics achieved significant regulatory approvals for Sephience and Kebilidi in 2025, driving substantial revenue growth despite challenges with Translarna's EU marketing authorization.

Rapid7 reports a slowdown in revenue growth and a slight dip in net income for 2025, while emphasizing its strategic focus on AI-driven security operations and platform consolidation.

MetLife, Inc. announced increased adjusted earnings and revenue growth in 2025, driven by strategic reorganization and key segment performance, despite a decline in GAAP net income.

IDEX Corporation achieved record net sales of $3,457.5 million in 2025, a 6% increase, driven by acquisitions and organic growth, while diluted EPS decreased by 3%.